查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2023534

生命科學分析領域的人工智慧市場：分析與預測（至 2035 年）—按類型、服務、技術、應用、部署模式和最終用戶分類

AI in Life Science Analytics Market Analysis and Forecast to 2035: Type, Services, Technology, Application, Deployment, End User
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球生命科學分析領域的人工智慧市場預計將從2025年的117億美元成長到2035年的418億美元，複合年成長率（CAGR）為12.3%。該市場採用率是透過製藥公司和研究機構的軟體許可和分析工作負載來衡量。 SAS Institute和Oracle等公司提供企業級平台。定價通常採用訂閱模式，每年費用從5萬美元到數百萬美元不等，具體取決於資料量和功能。成本受整合複雜性、分析能力和監管合規要求的影響。人工智慧在藥物發現和臨床研究中的日益普及正在推動該市場的應用和支出成長。

在生命科學分析市場中，人工智慧「類型」細分市場主要由預測分析主導。這是因為預測分析能夠利用歷史數據和即時數據預測生物學結果、藥物反應和疾病進展。這項功能在藥物研發和臨床試驗中極具價值，因為預測成功率可以顯著縮短時間和降低成本。基於預測分析洞察推薦最佳治療方案的處方分析也日益受到關注。生物數據量的不斷成長以及對數據驅動決策的需求是推動該市場先進分析方法發展的主要動力。

市場區隔
種類 說明分析、預測性分析、指示性分析、診斷性分析
服務 諮詢、實施、支援和維護
科技 機器學習、自然語言處理、電腦視覺、機器人技術
應用領域 藥物發現、臨床試驗、臨床前研究、監管合規
實作方法 雲端部署、本地部署、混合部署
最終用戶 製藥公司、生技公司、研究機構、受託研究機構

人工智慧的應用領域主導在藥物發現領域，這主要源自於加速開發新療法藥物的迫切需求。人工智慧分析有助於識別藥物標靶、分析分子間相互作用並最佳化候選化合物的選擇，從而縮短研發時間和降低成本。臨床試驗也是一個重要的應用領域，人工智慧能夠改善受試者招募、試驗設計和結果預測。此外，隨著生命科學工作流程中效率、準確性和合規性方面的人工智慧工具應用日益廣泛，其在臨床前研究和法規遵循方面的應用也在不斷擴展。

區域概覽

北美憑藉其強大的數位醫療基礎設施、先進的人工智慧生態系統以及高度集中的製藥和生物技術公司，在生命科學分析領域的人工智慧市場佔據最大佔有率。美國在人工智慧驅動的分析技術在藥物發現、臨床試驗、藥物安全檢測和精準醫療等領域的廣泛應用方面處於該地區領先地位。生命科學公司和技術供應商的大規模投資正在加速機器學習和預測分析技術與研究工作流程的整合。對數據驅動型醫療創新的強力的監管支持以及領先的雲端和人工智慧公司的存在，進一步鞏固了北美在全球市場的主導地位。

亞太地區預計將成為生命科學分析市場人工智慧領域複合年成長率最高的地區，這主要得益於醫療保健行業的快速數字化轉型以及對人工智慧和生物技術投資的不斷成長。中國、印度、日本和韓國等國正積極推動人工智慧在藥物研發、基因組學和臨床研究的應用。製藥業的擴張、臨床試驗活動的增加以及醫療數據的日益普及，都在推動對先進分析解決方案的需求。政府支持人工智慧創新的舉措以及生物技術Start-Ups與全球製藥公司之間合作的加強，進一步加速了這一成長，使亞太地區成為成長最快的區域市場。

主要趨勢和促進因素

對數據驅動的藥物發現和臨床決策的需求日益成長。

生命科學分析市場人工智慧發展的關鍵促進因素之一是藥物發現和臨床決策中對數據驅動方法日益成長的需求。傳統調查方法耗時耗力，而人工智慧能夠快速識別候選藥物、預測分子間相互作用並最佳化臨床試驗設計。製藥公司正擴大利用機器學習和預測分析來提高研發效率並降低失敗率。來自基因組學、蛋白質組學和真實世界證據（RWE）的生物醫學數據量不斷成長，進一步推動了人工智慧的應用。這些因素共同加速了人工智慧分析技術在全球生命科學研究和醫療應用中的整合。

人工智慧驅動的精準醫療和真實世界數據分析的擴展

人工智慧在生命科學分析市場的主要機會在於精準醫療和真實世界數據分析的擴展。人工智慧技術能夠整合和分析大規模患者數據，包括基因組學、電子健康記錄和穿戴式裝置輸入數據，從而開發高度個人化的治療策略。監管決策中對真實世界證據的日益重視進一步推動了對先進分析平台的需求。此外，製藥公司、人工智慧Start-Ups和醫療服務提供者之間的夥伴關係正在加速創新。雲端人工智慧平台的日益普及提高了擴充性和可訪問性，為全球市場創造了巨大的長期成長機會。

目錄

第1章：執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 說明分析
    • 預測分析
    • 指示性分析
    • 診斷分析
  • 市場規模及預測：依服務分類
    • 諮詢
    • 執行
    • 支援和維護
  • 市場規模及預測：依技術分類
    • 機器學習
    • 自然語言處理
    • 電腦視覺
    • 機器人技術
  • 市場規模及預測：依應用領域分類
    • 藥物發現
    • 臨床試驗
    • 臨床前研究
    • 監理合規
  • 市場規模及預測：依市場細分
    • 基於雲端的
    • 現場
    • 混合
  • 市場規模及預測：依最終用戶分類
    • 製藥公司
    • 生技公司
    • 研究機構
    • 受委託的研究機構

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • IBM
  • Microsoft
  • Google
  • Amazon
  • Oracle
  • SAS Institute
  • Cognizant
  • Accenture
  • IQVIA
  • Optum
  • Clarivate
  • Palantir Technologies
  • Flatiron Health
  • Tempus
  • Medidata Solutions
  • BioXcel Therapeutics
  • Exscientia
  • BenevolentAI
  • Insilico Medicine
  • Atomwise

第9章 關於我們

簡介目錄
Product Code: GIS34513

The global AI in Life Science Analytics Market is projected to grow from $11.7 billion in 2025 to $41.8 billion by 2035, at a compound annual growth rate (CAGR) of 12.3%. Adoption is measured through software licenses and analytics workloads across pharmaceutical and research organizations. Companies like SAS Institute and Oracle provide enterprise-level platforms. Pricing is typically subscription-based, ranging from USD 50,000 to several million annually depending on data scale and functionality. Costs are influenced by integration complexity, analytics capabilities, and regulatory compliance requirements. Increasing use of AI in drug discovery and clinical research is driving higher adoption and spending across this market.

The Type segment in the AI in Life Science Analytics Market is primarily dominated by predictive analytics, as it enables forecasting of biological outcomes, drug responses, and disease progression using historical and real-time data. This capability is highly valuable in drug discovery and clinical trials, where predicting success rates can significantly reduce time and costs. Prescriptive analytics is also gaining traction by recommending optimal actions based on predictive insights. The increasing volume of biological data and the need for data-driven decision-making are key factors driving the growth of advanced analytics types in this market.

Market Segmentation
TypeDescriptive Analytics, Predictive Analytics, Prescriptive Analytics, Diagnostic Analytics
ServicesConsulting, Implementation, Support and Maintenance
TechnologyMachine Learning, Natural Language Processing, Computer Vision, Robotics
ApplicationDrug Discovery, Clinical Trials, Preclinical Research, Regulatory Compliance
DeploymentCloud-Based, On-Premises, Hybrid
End UserPharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Research Organizations

The Application segment is led by drug discovery, driven by the growing need to accelerate the development of new therapeutics. AI-powered analytics help in identifying drug targets, analyzing molecular interactions, and optimizing candidate selection, thereby reducing R&D timelines and costs. Clinical trials are another major application, where AI improves patient recruitment, trial design, and outcome prediction. Additionally, applications in preclinical research and regulatory compliance are expanding, supported by the increasing adoption of AI tools to enhance efficiency, accuracy, and compliance in life sciences workflows.

Geographical Overview

North America holds the largest market share in the AI in Life Science Analytics Market due to its strong digital health infrastructure, advanced AI ecosystem, and high concentration of pharmaceutical and biotechnology companies. The United States leads the region with extensive adoption of AI-driven analytics in drug discovery, clinical trials, pharmacovigilance, and precision medicine. Major investments from life science firms and technology providers are accelerating integration of machine learning and predictive analytics into research workflows. Strong regulatory support for data-driven healthcare innovation and the presence of leading cloud and AI companies further reinforce North America's dominant position in the global market.

Asia Pacific is expected to register the highest CAGR in the AI in Life Science Analytics Market due to rapid digital transformation in healthcare and increasing investments in artificial intelligence and biotechnology. Countries such as China, India, Japan, and South Korea are actively promoting AI adoption in drug discovery, genomics, and clinical research. Expanding pharmaceutical manufacturing, rising clinical trial activities, and growing availability of healthcare data are driving demand for advanced analytics solutions. Government initiatives supporting AI innovation and increasing collaborations between biotech startups and global pharma companies further accelerate growth, making Asia Pacific the fastest-growing regional market.

Key Trends and Drivers

Increasing demand for data-driven drug discovery and clinical decision-making

A key driver of the AI in Life Science Analytics Market is the rising need for data-driven approaches in drug discovery and clinical decision-making. Traditional research methods are time-consuming and costly, while AI enables faster identification of drug candidates, prediction of molecular interactions, and optimization of clinical trial design. Pharmaceutical companies are increasingly leveraging machine learning and predictive analytics to enhance R&D efficiency and reduce failure rates. The growing volume of biomedical data from genomics, proteomics, and real-world evidence is further driving adoption. These factors collectively accelerate the integration of AI-powered analytics across life sciences research and healthcare applications globally.

Expansion of AI-enabled precision medicine and real-world data analytics

A major opportunity in the AI in Life Science Analytics Market lies in the expansion of precision medicine and real-world data analytics. AI technologies enable the integration and analysis of large-scale patient data, including genomics, electronic health records, and wearable device inputs, to develop highly personalized treatment strategies. Increasing adoption of real-world evidence in regulatory decision-making is further boosting demand for advanced analytics platforms. Additionally, partnerships between pharmaceutical companies, AI startups, and healthcare providers are accelerating innovation. The growing use of cloud-based AI platforms enhances scalability and accessibility, creating significant long-term growth opportunities in the global market.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type (Descriptive Analytics, Predictive Analytics, Prescriptive Analytics, Diagnostic Analytics)
  • 2.2 Key Market Highlights by Services (Consulting, Implementation, Support and Maintenance)
  • 2.3 Key Market Highlights by Technology (Machine Learning, Natural Language Processing, Computer Vision, Robotics)
  • 2.4 Key Market Highlights by Application (Drug Discovery, Clinical Trials, Preclinical Research, Regulatory Compliance)
  • 2.5 Key Market Highlights by Deployment (Cloud-Based, On-Premises, Hybrid)
  • 2.6 Key Market Highlights by End User (Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Research Organizations)

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Descriptive Analytics
    • 4.1.2 Predictive Analytics
    • 4.1.3 Prescriptive Analytics
    • 4.1.4 Diagnostic Analytics
  • 4.2 Market Size & Forecast by Services (2020-2035)
    • 4.2.1 Consulting
    • 4.2.2 Implementation
    • 4.2.3 Support and Maintenance
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Machine Learning
    • 4.3.2 Natural Language Processing
    • 4.3.3 Computer Vision
    • 4.3.4 Robotics
  • 4.4 Market Size & Forecast by Application (2020-2035)
    • 4.4.1 Drug Discovery
    • 4.4.2 Clinical Trials
    • 4.4.3 Preclinical Research
    • 4.4.4 Regulatory Compliance
  • 4.5 Market Size & Forecast by Deployment (2020-2035)
    • 4.5.1 Cloud-Based
    • 4.5.2 On-Premises
    • 4.5.3 Hybrid
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Pharmaceutical Companies
    • 4.6.2 Biotechnology Companies
    • 4.6.3 Research Institutes
    • 4.6.4 Contract Research Organizations

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Services
      • 5.2.1.3 Technology
      • 5.2.1.4 Application
      • 5.2.1.5 Deployment
      • 5.2.1.6 End User
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Services
      • 5.2.2.3 Technology
      • 5.2.2.4 Application
      • 5.2.2.5 Deployment
      • 5.2.2.6 End User
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Services
      • 5.2.3.3 Technology
      • 5.2.3.4 Application
      • 5.2.3.5 Deployment
      • 5.2.3.6 End User
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Services
      • 5.3.1.3 Technology
      • 5.3.1.4 Application
      • 5.3.1.5 Deployment
      • 5.3.1.6 End User
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Services
      • 5.3.2.3 Technology
      • 5.3.2.4 Application
      • 5.3.2.5 Deployment
      • 5.3.2.6 End User
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Services
      • 5.3.3.3 Technology
      • 5.3.3.4 Application
      • 5.3.3.5 Deployment
      • 5.3.3.6 End User
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Services
      • 5.4.1.3 Technology
      • 5.4.1.4 Application
      • 5.4.1.5 Deployment
      • 5.4.1.6 End User
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Services
      • 5.4.2.3 Technology
      • 5.4.2.4 Application
      • 5.4.2.5 Deployment
      • 5.4.2.6 End User
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Services
      • 5.4.3.3 Technology
      • 5.4.3.4 Application
      • 5.4.3.5 Deployment
      • 5.4.3.6 End User
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Services
      • 5.4.4.3 Technology
      • 5.4.4.4 Application
      • 5.4.4.5 Deployment
      • 5.4.4.6 End User
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Services
      • 5.4.5.3 Technology
      • 5.4.5.4 Application
      • 5.4.5.5 Deployment
      • 5.4.5.6 End User
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Services
      • 5.4.6.3 Technology
      • 5.4.6.4 Application
      • 5.4.6.5 Deployment
      • 5.4.6.6 End User
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Services
      • 5.4.7.3 Technology
      • 5.4.7.4 Application
      • 5.4.7.5 Deployment
      • 5.4.7.6 End User
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Services
      • 5.5.1.3 Technology
      • 5.5.1.4 Application
      • 5.5.1.5 Deployment
      • 5.5.1.6 End User
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Services
      • 5.5.2.3 Technology
      • 5.5.2.4 Application
      • 5.5.2.5 Deployment
      • 5.5.2.6 End User
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Services
      • 5.5.3.3 Technology
      • 5.5.3.4 Application
      • 5.5.3.5 Deployment
      • 5.5.3.6 End User
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Services
      • 5.5.4.3 Technology
      • 5.5.4.4 Application
      • 5.5.4.5 Deployment
      • 5.5.4.6 End User
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Services
      • 5.5.5.3 Technology
      • 5.5.5.4 Application
      • 5.5.5.5 Deployment
      • 5.5.5.6 End User
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Services
      • 5.5.6.3 Technology
      • 5.5.6.4 Application
      • 5.5.6.5 Deployment
      • 5.5.6.6 End User
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Services
      • 5.6.1.3 Technology
      • 5.6.1.4 Application
      • 5.6.1.5 Deployment
      • 5.6.1.6 End User
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Services
      • 5.6.2.3 Technology
      • 5.6.2.4 Application
      • 5.6.2.5 Deployment
      • 5.6.2.6 End User
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Services
      • 5.6.3.3 Technology
      • 5.6.3.4 Application
      • 5.6.3.5 Deployment
      • 5.6.3.6 End User
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Services
      • 5.6.4.3 Technology
      • 5.6.4.4 Application
      • 5.6.4.5 Deployment
      • 5.6.4.6 End User
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Services
      • 5.6.5.3 Technology
      • 5.6.5.4 Application
      • 5.6.5.5 Deployment
      • 5.6.5.6 End User

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 IBM
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Microsoft
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Google
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Amazon
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Oracle
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 SAS Institute
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Cognizant
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Accenture
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 IQVIA
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Optum
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Clarivate
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Palantir Technologies
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Flatiron Health
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Tempus
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Medidata Solutions
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 BioXcel Therapeutics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Exscientia
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 BenevolentAI
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Insilico Medicine
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Atomwise
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us